发明名称 |
METHODS FOR TREATING CANCER USING NUCLEIC TARGETING MDM2 OR MYCN |
摘要 |
Aspects of the invention relate to methods for treating cancer by administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule that is directed against a gene encoding mouse double minute 1 homolog (MDM1), mouse double minute 2 homolog (MDM2), mouse double minute 3 homolog (MDM3), mouse double minute 4 homolog (MDM4) or V-myc myelocytomatosis viral related oncogene (MYCN) for treating cancer. Further aspects of the invention relate to nucleic acid molecules and compositions comprising nucleic acid molecules. |
申请公布号 |
EP3137119(A2) |
申请公布日期 |
2017.03.08 |
申请号 |
EP20150785528 |
申请日期 |
2015.04.28 |
申请人 |
RXi Pharmaceuticals Corporation |
发明人 |
BYRNE, Michael;BULOCK, Karen, G.;CARDIA, James |
分类号 |
A61K48/00 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|